“Dr Reddy’s to sell Hyderabad API unit to Therapiva: Dr Reddy’s Laboratories said it has entered into a definitive agreement for the sale of its API manufacturing business unit in Jeedimetla, Hyderabad, to Therapiva,” reported Mint.
AZB & Partners advised
2018-10-15
Deal value: Not disclosed
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
No comments yet: share your views